GP Strategies buys out IC Axon to deliver training to pharma customers
Category: #health  By Pankaj Singh  Date: 2018-05-05
  • share
  • Twitter
  • Facebook
  • LinkedIn

GP Strategies buys out IC Axon to deliver training to pharma customers

GP Strategies Corporation, the international performance improvement solutions provider, has scarcely declared that it has purchased IC Axon, a leader in developing science-oriented training for life science and pharmaceutical companies. The acquisition is expected to strengthen GP Strategies' capabilities to deliver digital learning and comprehensive sales training services to its global pharmaceutical customer base.

For the uninitiated, IC Axon was founded in 1995 with its headquarters in Montreal, Canada. The company engages in designing and deploying customized clinical and sales training solutions for clients across the globe. IC Axon comprises a large team of in-house experts that includes editors, medical writers and dedicated referencing systems managers. IC Axon focuses on blending learning solutions and leveraging digital innovations, while also holding credit for putting together an award-winning visual communications team.

Don Duquette, Executive Vice President, Workforce Excellence at GP Strategies reportedly said that the existing GP Strategies team will be highly complemented with the addition of learning and development expertise that IC Axon will bring to the team. GP Strategies will now be able to offer its pharmaceutical customers expanded competence that delivers the most successful digital learning approaches. Duquette added that with the acquisition, GP Strategies is well on its way to become one of the most experienced and credentialed pharmaceutical sales training companies across the globe.

Carole Gins, CEO of IC Axon also welcomed the opportunity to combine IC Axon’s offerings with GP Strategies as a means to create a truly global, full-service pharmaceutical sales training agency. She added that GP Strategies and IC Axon can be said to be closely aligned as strategic partners when it comes to delivering high-quality services to customers.

Earlier in 2018, GP Strategies had also entered into a reseller agreement with ManchesterCF to offer training programs specifically designed for international banking and financial intelligence units within financial services and public-sector industries



About Author

Pankaj Singh

Email: [email protected]om   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Anova Enterprises expands AnovaOS™ to boost clinical development
Anova Enterprises expands AnovaOS™ to boost clinical development
By Pankaj Singh

The U.S-based Anova Enterprises, Inc. (Anova) has reportedly expanded the AnovaOS™ technology platform in order to boost the development of promising novel treatments. The platform brings pharmaceutical companies...

Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India
Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India
By Pankaj Singh

India’s Drugs Controller General (DCGI) has approved Pune-based Serum Institute of India (SII) to restart the clinical trial of the Oxford/AstraZeneca COVID-19 vaccine in India.

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results
By Pankaj Singh

Everest Medicines announced the top-line results from the Phase 1 clinical trial of Taniborbactam with cefepime for treating infections caused by multi-drug resistant pathogens in China. Everest Medicines is a biopharm...